Skip to main content
Premium Trial:

Request an Annual Quote

Bioinstrumentation Sector Poised to Grow 15% in 2001

NEW YORK, Jan 22 – The bioinstrumentation sector is forecast to grow 15 percent this year to $4.3 billion, Strategic Directions International, a market research and consulting firm that tracks the instrument industry, said in a recent edition of its Instrument Business Outlook report.

Bioinstrumentation accounts for nearly 20 percent of all analytical instrument sales, SDI said. According to SDI bioinstrumentation includes all instruments for DNA sequencing, nucleic acid amplification, synthesis, electrophoresis and flow cytometry, as well as microarrays and biosensors.  

Academics, pharmaceutical companies, and biotech firms are the leading users of bioinstrumentation. SDI noted that the DNA sequencers and microarrays are among the fastest growing markets.

SDI publishes the Instrument Business Outlook twice a month.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.